Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience

Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B.. Lung Cancer. 2016; 111-6: p.111-6. doi:10.1016/j.lungcan.2016.06.020 10.1016/j.lungcan.2016.06.020. Epub 2016 Jul 1.

Article